Our results showing decreased expression levels of P2ry12 during IRI are in line with previous studies investigating CNS disorders such as Alzheimer’s disease [12,13], multiple sclerosis [14], and amyotrophic lateral sclerosis [28]. The gene discussed is P2RY12; the disease is early-onset autosomal dominant Alzheimer disease.